These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2618720)

  • 1. [Studies on eliminating the influence of random errors of analytical methods on the content uniformity test].
    Luo X; Wang X; Tao QF
    Yao Xue Xue Bao; 1989; 24(9):697-701. PubMed ID: 2618720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the correction of systematic errors of analytical methods used in the content uniformity test].
    Guo XJ; He CF; Luo X; Wang X
    Yao Xue Xue Bao; 1992; 27(9):695-700. PubMed ID: 1293943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the analytical error on content uniformity sampling plans.
    Norberg R
    Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537
    [No Abstract]   [Full Text] [Related]  

  • 5. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
    Hauck WW; Shaikh R
    J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of content uniformity test to tablet preparations.
    Kovács I; Hadady KK; Darbai MJ
    Pharmazie; 1980; 35(10):609-12. PubMed ID: 6779284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined wavelet transform-artificial neural network use in tablet active content determination by near-infrared spectroscopy.
    Chalus P; Walter S; Ulmschneider M
    Anal Chim Acta; 2007 May; 591(2):219-24. PubMed ID: 17481412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transmission and reflection modalities for measuring content uniformity of pharmaceutical tablets with near-infrared spectroscopy.
    Xiang D; LoBrutto R; Cheney J; Wabuyele BW; Berry J; Lyon R; Wu H; Khan MA; Hussain AS
    Appl Spectrosc; 2009 Jan; 63(1):33-47. PubMed ID: 19146717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-line content uniformity determination of tablets using low-resolution Raman spectroscopy.
    Wikström H; Romero-Torres S; Wongweragiat S; Williams JA; Grant ER; Taylor LS
    Appl Spectrosc; 2006 Jun; 60(6):672-81. PubMed ID: 16808869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodology for the validation of analytical methods involved in uniformity of dosage units tests.
    Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
    Anal Chim Acta; 2013 Jan; 760():46-52. PubMed ID: 23265732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: USP content uniformity test.
    Madan PL
    J Pharm Sci; 1976 Jan; 65(1):VIII. PubMed ID: 1255410
    [No Abstract]   [Full Text] [Related]  

  • 12. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a blend-sampling technique to assess the uniformity of a powder mixture.
    Garcia TP; Wilkinson SJ; Scott JF
    Drug Dev Ind Pharm; 2001 Apr; 27(4):297-307. PubMed ID: 11411897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical characteristics of the USP content uniformity test.
    Pedersen AO; Torud Y
    Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the pharmaceutical quality of some quinine preparations sold in Nigeria.
    Nnamdi JA; Arhewoh IM; Okhamafe AO; Enato EF
    Med Princ Pract; 2009; 18(3):193-7. PubMed ID: 19349721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Content uniformity test of tablets by nonaqueous titration method.
    Safarík L
    Pharmazie; 1987 Feb; 42(2):129-30. PubMed ID: 3602052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.
    Kyriakides D; Panderi I
    Anal Chim Acta; 2007 Feb; 584(1):153-9. PubMed ID: 17386598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The USP content uniformity test. Analysis and proposals.
    Setnikar I
    Pharm Acta Helv; 1974; 49(9-10):302-8. PubMed ID: 4462139
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of net analyte signal (NAS) in near infrared spectroscopy pharmaceutical applications: interpretability and figures of merit.
    Sarraguça MC; Lopes JA
    Anal Chim Acta; 2009 May; 642(1-2):179-85. PubMed ID: 19427474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.